Cargando…

Bone cancer : primary bone cancers and bone metastases /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Heymann, Dominique (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: San Diego, California ; Waltham, Massachusetts : Elsevier/Academic Press, 2015.
Edición:Second edition.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Epidemiology of primary bone tumors and economical aspects of bone metastases
  • Tumor: bone interactions: there is no place like bone
  • Stem cell niches in the bone: bone marrow organ and their significance for hematopoietic and non-hematopoietic cancer
  • Deregulation of osteoblast differentiation in primary bone cancers
  • Contribution of osteoclasts to the bone: tumor niche
  • Involvement of osteocytes in cancer bone niche
  • Role of mesenchymal stem cells in bone cancer; initiation, propagation and metastasis
  • Gap junction in bone remodeling and in primary bone tumors: osteosarcoma and Ewing sarcoma
  • Macrophages and pathophysiology of bone cancers
  • Cytokines and bone cancers
  • Technical aspects: how do we best prepare bone samples for proper histological analysis?
  • Bone remodeling markers and bone cancer
  • Cancer stem cells in representative bone tumors: osteosarcoma, Ewing sarcoma and metastases from breast and prostate carcinomas
  • Homeobox genes from the Dlx family and bone cancers
  • MicroRNA implication in therapeutic resistance and metastatic dissemination of bone-associated tumors
  • Hypoxia and angiogenesis: from primary tumor to bone metastasis
  • Modeling osteosarcoma: in vitro and in vivo approaches
  • Stemness markers of osteosarcoma
  • Molecular pathology of osteosarcoma
  • Gene and proteomic profiling of osteosarcoma
  • Ewing sarcoma family of tumors
  • Biology of Ewing sarcoma
  • Osteoclast-rich lesions of bone: a clinical and molecular overview
  • Markers for bone sarcomas
  • Margins and bone tumors: what are we talking about?
  • Cytogenetics of bone tumors
  • Genetic aspects of bone tumors
  • Cytogenetic and molecular genetic alterations in bone tumors
  • Genetics of giant cell tumors of bone
  • Mammalian models of bone sarcomas
  • Zebrafish models for studying bone cancers: mutants, transgenic fish and embryos
  • Imaging of bone sarcomas
  • New therapeutic targets in Ewing sarcoma: from pre-clinical proof-of-concept to clinical trials
  • Therapeutic approaches for bone sarcomas
  • Chondrosarcoma of bone: diagnosis and therapy
  • Apoptosis and drug resistance in malignant bone tumors
  • Giant cell tumors of bone
  • EMT process in bone metastasis
  • Histopathology of skeletal metastases
  • Disseminated tumor cells in bone marrow of cancer patients.
  • MicroRNA-mediated regulation of bone metastasis formation: from primary tumors to skeleton
  • Myeloma and osteoclast relationship
  • In vivo models used in studies of bone metastases
  • Interventional radiologic techniques in management of bone tumors
  • Diagnosis of bone metastases in urological malignancies : an update
  • Pre-clinical molecular imaging of "the seed and the soil" in bone metastasis
  • Mechanisms and management of bone cancer pain
  • Bone cancer: current opinion in palliative care
  • Involvement of sympathetic nerves in bone metastasis
  • Pain control with palliative radiotherapy in patients with bone metastases
  • Cellular and molecular actions of bisphosphonates
  • The use of nitrogen-bisphosphonates to capture the potent anti-tumor arsenal of human peripheral blood [gamma delta] T cells for the treatment of bone cancer metastasis
  • Systemic treatment of bone metastases in castration-resistant prostate cancer (CRPC): pre-clinical to clinical point of view
  • A multi-targeted approach to treating bone metastases
  • Bone metastases in prostate cancer: pathophysiology, clinical complications, actual treatment, and future directions
  • Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases
  • Bone metastases : current status of bone-targeted treatments
  • Bone metastases, clinical trials II: zoledronic acid and denosumab in the prevention of bone metastases.